Long-acting buprenorphine is a promising new treatment for opioid use disorder, but it usually requires a seven-day stabilization period before initiation. Here, researchers develop and evaluate a novel protocol for initiating long-acting injectable buprenorphine in a single day. The trial is small, but results are promising.

By successfully completing the test you will be awarded a certificate for 2 CME credit.

The FDA recently approved donanemab for early Alzheimer’s, offering new hope by slowing cognitive decline.

This umbrella review looked at modifiable risk factors for late life depression—and only two stood out. 

For years, moderate drinking was seen as harmless or even beneficial. This study challenges that, revealing how even modest alcohol consumption can raise brain iron levels and impair cognitive function.
 

Smart dosing and vigilant monitoring can turn the often-feared lithium into a safe, effective solution for older adults.

Dr. Pérez Palmer explores health disparities in geriatric psychiatry, focusing on how social determinants affect dementia diagnosis and treatment among underrepresented populations, while addressing strategies to improve equitable care for older adults.
 

Dr. Black delves into the intersection of ageism and racism in healthcare, highlighting how both impact patient trust and clinical decisions. She offers strategies for clinicians to acknowledge patient concerns, validate experiences of injustice, and build trust through empathetic care.

After reading these articles, you should be able to…